arginyl-glycyl-aspartic acid has been researched along with Pituitary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Li, W; Liu, Y; Tian, X; Zhang, J; Zhuang, G | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Pituitary Neoplasms
| Article | Year |
|---|---|
RGD-FasL induces apoptosis of pituitary adenoma cells.
Topics: Apoptosis; Caspases; Cell Cycle; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Humans; Mitogen-Activated Protein Kinase 9; Oligopeptides; Pituitary Neoplasms; Proto-Oncogene Proteins c-bcl-2; RANK Ligand; Receptors, Tumor Necrosis Factor, Member 6b | 2008 |